Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-26T15:20:03.263Z Has data issue: false hasContentIssue false
  • English
  • Français

Assessment and treatment of dysthymia. The development of the Cornell dysthymia rating scale

Published online by Cambridge University Press:  16 April 2020

J Cohen
J Cohen*
Affiliation:
CNS Clinical Research, Bristol-Myers Squibb Company, Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT06492-7660, USA
Get access

Summary

The understanding and classification of persistently depressed mood has undergone many changes since the term ‘dysthymia’ was first used nearly 150 years ago. Originally it was applied to both melancholia and mania; later it was applied to depressive personality. The Diagnostic and Statistical Manual (DSM)-III in 1980 and in subsequent updates classified dysthymia as a mood disorder, characterized by a frequently insidious onset and a course that is chronic and unremitting. The assessment of clinical response in the pharmacologic treatment of dysthymia has been more difficult than that for major depression. The Hamilton Rating Scale for Depression, among others, is oriented towards episodic rather than chronic states of depression. A new rating scale, the Cornell Dysthymia Rating Scale, has been developed to better assess milder symptomatology in chronically depressed patients. Early studies suggest its utility, but further validation of the scale is needed in patients with dysthymia and without major depression.

Keywords

dysthymiamajor depressionCornell Dysthymia Rating Scale
Type
Research Article
Information
European Psychiatry , Volume 12 , Issue 4 , 1997 , pp. 190 - 193
Copyright
Copyright © Elsevier, Paris 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn (DSM-III). Washington, DC: American Psychiatric Association, 1980Google Scholar
American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 3rd edn Revised (DSM-III-R). Washington, DC: American Psychiatric Association, 1987Google Scholar
American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington, DC: American Psychiatric Association, 1994Google Scholar
(suppl)Angst, JStabl, MEfficacy of moclobemide in different patient groups: a meta-analysis of studies Psychopharmacol Bull 106 1992 109–113CrossRefGoogle ScholarPubMed
Beck, ATWard, CHMendelson, MMock, JEErbaugh, JKAn inventory for measuring depression Arch Gen Psychiatry 4 1961 561–571CrossRefGoogle ScholarPubMed
Feighner, JPRobins, EGuze, SBWoodruff, RAWinokur, GDiagnostic criteria for use in psychiatric research Arch Gen Psychiatry 26 1972 57–63CrossRefGoogle ScholarPubMed
Frances, AJKocsis, JHMarin, Det al. Implications of recent research on dysthymic disorders: diagnostic criteria for dysthymic disorder Psychopharmacol Bull 25 1989 325–329Google Scholar
Hamilton, MA rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56–62CrossRefGoogle ScholarPubMed
Hamilton, MDevelopment of a rating scale for primary depression illness Br J Soc Clin Psychol 6 1967 278–296CrossRefGoogle Scholar
Hellerstein, DJYanowitch, PRosenthal, Jet al. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia Am J Psychiatry 1508 1993 1169–1175Google ScholarPubMed
Howland, RHPharmacotherapy of dysthymia: a review J Clin Psychopharmacol 112 1991 83–92CrossRefGoogle ScholarPubMed
Jelliffe, SESome historical phases of manic-depressive synthesis Assoc Res Nerv Ment Dis 11 1931 3–47Google Scholar
Klerman, GLThe significance of DSM-III in American psychiatry In: Spitzer, RLWilliams, JBWSkodol, AE 1 1983 International Perspectives on DSM-III Washington, DC3–25Google Scholar
Kocsis, JHFrancis, AJVoss, Cet al. Imipramine treatment for chronic depression Arch Gen Psychiatry 45 1988 253–257CrossRefGoogle ScholarPubMed
Mason, BJKocsis, JHLeon, ACet al. Measurement of severity and treatment response in dysthymia Psychiatr Ann 23 1993 625–631CrossRefGoogle Scholar
McCullough, JPMcCune, KJKaye, ALet al. One-year prospective replication study of an untreated sample of community dysthymic subjects J Nerv Ment Dis 1827 1994 396–401CrossRefGoogle Scholar
Nardi, ECapponi, RCosta, DAet al. Moclobemide compared with imipramine in the treatment of chronic depression Clin Neuropharmacol 15suppl 11992 1488CrossRefGoogle Scholar
Spitzer, RLEndicott, JRobbins, EResearch Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders 1975 New York State Department of Mental Hygiene, Biometrics Branch New YorkGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.